XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
1.350
-0.070 (-4.93%)
Nov 4, 2024, 4:00 PM EST - Market closed
XORTX Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Cash & Equivalents | 3.08 | 3.45 | 10.43 | 14.87 | 0.17 | 0.06 | Upgrade
|
| Cash & Short-Term Investments | 3.08 | 3.45 | 10.43 | 14.87 | 0.17 | 0.06 | Upgrade
|
| Cash Growth | -50.06% | -66.96% | -29.83% | 8582.07% | 192.20% | -77.46% | Upgrade
|
| Other Receivables | 0.02 | 0.06 | 0.08 | 0.04 | 0.01 | 0.01 | Upgrade
|
| Receivables | 0.02 | 0.06 | 0.08 | 0.04 | 0.01 | 0.01 | Upgrade
|
| Prepaid Expenses | 0.21 | 0.24 | 0.38 | 0.44 | 0.26 | 0.01 | Upgrade
|
| Other Current Assets | 0.05 | 0.32 | - | 0.56 | 1.61 | 0.74 | Upgrade
|
| Total Current Assets | 3.36 | 4.07 | 10.9 | 15.91 | 2.06 | 0.82 | Upgrade
|
| Property, Plant & Equipment | 0.07 | 0.02 | 0.09 | - | - | 0 | Upgrade
|
| Other Intangible Assets | 0.17 | 0.18 | 0.2 | 0.2 | 0.23 | 0.27 | Upgrade
|
| Other Long-Term Assets | 1.2 | 1.2 | 1.19 | 1.27 | - | - | Upgrade
|
| Total Assets | 4.8 | 5.47 | 12.37 | 17.38 | 2.29 | 1.09 | Upgrade
|
| Accounts Payable | 0.27 | 0.2 | 1.29 | 0.32 | 0.39 | 0.61 | Upgrade
|
| Accrued Expenses | 0.17 | 0.09 | 0.15 | 0.23 | 0.64 | 0.54 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 0.05 | Upgrade
|
| Current Portion of Leases | - | 0.01 | 0.07 | - | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 0.1 | Upgrade
|
| Total Current Liabilities | 0.44 | 0.29 | 1.51 | 0.55 | 1.03 | 1.3 | Upgrade
|
| Long-Term Leases | 0.08 | - | 0.01 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 1.57 | 0.53 | 3.85 | 3.63 | - | - | Upgrade
|
| Total Liabilities | 2.09 | 0.83 | 5.38 | 4.18 | 1.03 | 1.3 | Upgrade
|
| Common Stock | 17.87 | 17.06 | 16.52 | 16.09 | 8.26 | 5.86 | Upgrade
|
| Retained Earnings | -20.7 | -17.85 | -15.7 | -7.98 | -8.04 | -6.76 | Upgrade
|
| Comprehensive Income & Other | 5.54 | 5.44 | 6.17 | 5.09 | 1.04 | 0.68 | Upgrade
|
| Shareholders' Equity | 2.7 | 4.64 | 7 | 13.2 | 1.26 | -0.21 | Upgrade
|
| Total Liabilities & Equity | 4.8 | 5.47 | 12.37 | 17.38 | 2.29 | 1.09 | Upgrade
|
| Total Debt | 0.08 | 0.01 | 0.08 | - | - | 0.05 | Upgrade
|
| Net Cash (Debt) | 2.99 | 3.44 | 10.36 | 14.87 | 0.17 | 0.01 | Upgrade
|
| Net Cash Growth | -51.06% | -66.82% | -30.35% | 8582.07% | 2095.50% | -96.40% | Upgrade
|
| Net Cash Per Share | 1.28 | 1.73 | 7.00 | 13.59 | 0.23 | 0.01 | Upgrade
|
| Filing Date Shares Outstanding | 2.9 | 2.9 | 2 | 1.44 | 1.04 | 0.77 | Upgrade
|
| Total Common Shares Outstanding | 2.9 | 2 | 1.67 | 1.44 | 0.77 | 0.6 | Upgrade
|
| Working Capital | 2.92 | 3.77 | 9.38 | 15.36 | 1.02 | -0.48 | Upgrade
|
| Book Value Per Share | 0.93 | 2.32 | 4.19 | 9.15 | 1.64 | -0.36 | Upgrade
|
| Tangible Book Value | 2.54 | 4.47 | 6.8 | 13 | 1.02 | -0.48 | Upgrade
|
| Tangible Book Value Per Share | 0.87 | 2.23 | 4.07 | 9.01 | 1.33 | -0.81 | Upgrade
|
| Machinery | 0.02 | 0.02 | 0.02 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.